193 related articles for article (PubMed ID: 26721242)
21. [Optimization of therapy using cardiac glycosides].
Ziesenhenn K; Behn P
Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
[TBL] [Abstract][Full Text] [Related]
22. Congestive heart failure and disorders of the heart beat.
Weaver T; Eisold JF
Dent Clin North Am; 1996 Jul; 40(3):543-61. PubMed ID: 8829045
[TBL] [Abstract][Full Text] [Related]
23. [Digitalis preparations in pediatric practice].
Olariu-Ungureanu A; Săvulescu M
Pediatria (Bucur); 1972; 21(4):369-78. PubMed ID: 4661113
[No Abstract] [Full Text] [Related]
24. Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
Han LN; Guo SL; Lin XM; Shi XM; Zang CB; Yang LM; Ding GL
Genet Mol Res; 2014 Sep; 13(3):7262-74. PubMed ID: 25222231
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides].
Smielak-Korombel W
Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985
[No Abstract] [Full Text] [Related]
26. [Age-dependent regulation of cardiac glycoside receptors].
Erdmann E; Brown L; Lorenz B; Kreuzer E; Kemkes B; Weinhold C; Holper K; Klövekorn W
Z Kardiol; 1985; 74 Suppl 7():33-8. PubMed ID: 3004053
[TBL] [Abstract][Full Text] [Related]
27. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
[TBL] [Abstract][Full Text] [Related]
28. [Action mechanism of cardioactive glycosides in pathophysiologic conditions].
Bolte HD
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():19-27. PubMed ID: 611942
[No Abstract] [Full Text] [Related]
29. [Treatment of congestive heart failure with cardiac glycosides. I. New theses in the principles of treatment].
Tomov I
Vutr Boles; 1980; 19(6):7-14. PubMed ID: 7210653
[No Abstract] [Full Text] [Related]
30. [Cardioactive glycosides].
Egidi E
Minerva Nipiol; 1967; 17(4):121-31. PubMed ID: 5620853
[No Abstract] [Full Text] [Related]
31. [Value of the clinical use of proscillaridin A].
Ratti G; Rocca F; Savastano A
Clin Ter; 1966 Sep; 38(5):413-24. PubMed ID: 5993561
[No Abstract] [Full Text] [Related]
32. [Treatment of heart failure, with special consideration of iatrogenic complications].
Lüderitz B; Avenhaus H
Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
[No Abstract] [Full Text] [Related]
33. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative studies on the therapeutic range of cardiac glycosides].
Diederen W; Kadatz R
Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
[No Abstract] [Full Text] [Related]
35. [Cardiac glycoside therapy of congestive heart failure. II].
Tomov I
Vutr Boles; 1981; 20(1):1-9. PubMed ID: 7245720
[No Abstract] [Full Text] [Related]
36. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies.
Lilleberg J; Ylönen V; Lehtonen L; Toivonen L
Scand Cardiovasc J; 2004 May; 38(2):80-4. PubMed ID: 15204232
[TBL] [Abstract][Full Text] [Related]
37. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
[TBL] [Abstract][Full Text] [Related]
38. [Individual glycoside therapy using serum concentration determination in canine heart failure].
Staudacher G
Dtsch Tierarztl Wochenschr; 1989 May; 96(6):308-10. PubMed ID: 2758985
[TBL] [Abstract][Full Text] [Related]
39. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
Haustein KO; Graumann G; Stephan B
Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
[TBL] [Abstract][Full Text] [Related]
40. Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010.
Kim SJ; Ioannides SJ; Elwood JM
Aust N Z J Public Health; 2015 Apr; 39(2):148-52. PubMed ID: 25715883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
